Skip to main content
Year archive

Immunome Inc. — 2023 filings

All 83 regulatory filings released by Immunome Inc. (IMNM) in 2023, sourced directly from the official regulator.

83 Filings
2023 Period
2023 filings (83)
Filing Released Lang
Board/Management Information
2023-12-29 English
Regulatory Filings
2023-12-26 English
Director's Dealing
2023-12-16 English
Director's Dealing
2023-12-16 English
Director's Dealing
2023-12-06 English
Regulatory Filings
2023-11-28 English
Regulatory Filings
2023-11-22 English
Regulatory Filings
2023-11-22 English
Regulatory Filings
2023-11-20 English
S-3
Capital/Financing Update
2023-11-16 English
Investor Presentation
2023-11-15 English
Earnings Release
2023-11-09 English
Director's Dealing
2023-11-09 English
Director's Dealing
2023-11-09 English
Interim / Quarterly Report Q3 2023
2023-11-09 English
Board/Management Information
2023-11-08 English
Capital/Financing Update
2023-11-01 English
Director's Dealing
2023-10-31 English
Director's Dealing
2023-10-31 English
Director's Dealing
2023-10-31 English
Director's Dealing
2023-10-20 English
Director's Dealing
2023-10-13 English
Director's Dealing
2023-10-13 English
Director's Dealing
2023-10-13 English
Major Shareholding Notification
2023-10-12 English
Director's Dealing
2023-10-12 English
Major Shareholding Notification
2023-10-12 English
Major Shareholding Notification
2023-10-12 English
Major Shareholding Notification
2023-10-12 English
Director's Dealing
2023-10-04 English
Director's Dealing
2023-10-04 English
Director's Dealing
2023-10-04 English
Director's Dealing
2023-10-04 English
Director's Dealing
2023-10-04 English
Capital/Financing Update
2023-10-04 English
Director's Dealing
2023-10-03 English
Regulatory Filings
2023-09-21 English
Regulatory Filings
2023-09-21 English
Regulatory Filings
2023-08-29 English
Proxy Solicitation & Information Statement
2023-08-28 English
Regulatory Filings
2023-08-25 English
M&A Activity
2023-08-25 English
Regulatory Filings
2023-08-11 English
Earnings Release
2023-08-09 English
Interim / Quarterly Report Q2 2023
2023-08-09 English
S-4
Merger & Acquisition
2023-08-08 English
Major Shareholding Notification
2023-07-07 English
Investor Presentation
2023-07-05 English
Investor Presentation
2023-07-05 English
M&A Activity
2023-06-29 English
M&A Activity
2023-06-29 English
Merger & Acquisition
2023-06-29 English
Declaration of Voting Results & Voting Rights Announcements
2023-06-13 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Director's Dealing
2023-06-12 English
Earnings Release
2023-05-05 English
Interim / Quarterly Report Q1 2023
2023-05-05 English
ARS
Annual Report
2023-04-20 English
Proxy Solicitation & Information Statement
2023-04-20 English
Proxy Solicitation & Information Statement
2023-04-20 English
Proxy Solicitation & Information Statement
2023-04-07 English
Capital/Financing Update
2023-03-16 English
Regulatory Filings
2023-03-16 English
Earnings Release
2023-03-16 English
Annual Report FY 2022
2023-03-16 English
Major Shareholding Notification
2023-02-14 English
Investor Presentation
2023-01-30 English
Major Shareholding Notification
2023-01-17 English
Director's Dealing
2023-01-17 English
Director's Dealing
2023-01-17 English
Director's Dealing
2023-01-17 English
Director's Dealing
2023-01-17 English
Regulatory Filings
2023-01-06 English
Regulatory Filings
2023-01-06 English